All stock lists
LeonaBio, Inc. (NASDAQ:LONA)
US · Delayed Price · Currency is USD
Also listed: ATHAHealthcare · Biotechnology
4.91-0.05 (-1.01%)
Market cap
$19.4M
Insider Score
Health Score
Analyst consensus
Listed since
Sep 18, 2020
Website
Insider Score
––Not scored
LONA Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
LONA analyst forecast
LONA analyst consensus
Moderate Buy2 ratings
Buy 2 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
LONA 12-month price target
$17.50+256.4% upsideaverage of 2 firms
$20.00High
$15.00Low
LONA ratings mix, last 12 months
Buy Hold Sell
Best analysts covering LONA
- Mizuho0%success rate · -23.6% avg return · 2 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
LONA analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Mizuho | Outperform | $15.00 | +83.6% | Reiterated | 2026-08-19 | |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-08-17 |
| — | Citizens | Market Outperform | — | — | Upgraded | 2026-07-30 |
| Piper Sandler | — | $20.00 | +106.8% | — | 2026-05-27 | |
| — | Mizuho | Outperform | — | — | Upgraded | 2026-02-19 |
| Mizuho Securities | — | $4.00 | +4.4% | — | 2025-09-19 | |
| — | JMP Securities | Outperform | — | — | Reiterated | 2023-08-10 |
| — | Mizuho | Buy | — | — | Reiterated | 2023-05-14 |
| — | BTIG | Buy | — | — | Reiterated | 2023-03-29 |
| — | JMP Securities | Outperform | — | — | Reiterated | 2023-03-24 |
| — | Mizuho | Buy | — | — | Reiterated | 2022-07-07 |
| — | Stifel | Hold | — | — | Downgraded | 2022-06-22 |
| Jefferies | Hold | $3.00 | +5.3% | Downgraded | 2022-06-22 | |
| — | JMP Securities | Market Perform | — | — | Downgraded | 2022-06-22 |
| — | BTIG | Buy | — | — | Reiterated | 2022-05-10 |
| — | Berenberg | Buy | — | — | Reiterated | 2022-04-21 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2021-12-15 |
LONA earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2025-11-06 | -1.06 | -1.68 | $0 | $0 |
| 2026-03-26 | -1.35 | -18.92 | $0 | $0 |
| 2026-05-07 | -2.28 | -1.73 | $0 | $0 |
| 2026-08-14 | -1.39 | -0.80 | $0 | $0 |
| 2026-11-05Upcoming | -0.69 | — | $0 | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.